Genetic correlation between multiple myeloma and chronic lymphocytic leukaemia provides evidence for shared aetiology.

View/ Open
Date
2018-12-21ICR Author
Author
Went, M
Sud, A
Speedy, H
Sunter, NJ
Försti, A
Law, PJ
Johnson, DC
Mirabella, F
Holroyd, A
Li, N
Orlando, G
Weinhold, N
van Duin, M
Chen, B
Mitchell, JS
Mansouri, L
Juliusson, G
Smedby, KE
Jayne, S
Majid, A
Dearden, C
Allsup, DJ
Bailey, JR
Pratt, G
Pepper, C
Fegan, C
Rosenquist, R
Kuiper, R
Stephens, OW
Bertsch, U
Broderick, P
Einsele, H
Gregory, WM
Hillengass, J
Hoffmann, P
Jackson, GH
Jöckel, K-H
Nickel, J
Nöthen, MM
da Silva Filho, MI
Thomsen, H
Walker, BA
Broyl, A
Davies, FE
Hansson, M
Goldschmidt, H
Dyer, MJS
Kaiser, M
Sonneveld, P
Morgan, GJ
Hemminki, K
Nilsson, B
Catovsky, D
Allan, JM
Houlston, RS
Type
Journal Article
Metadata
Show full item recordAbstract
The clustering of different types of B-cell malignancies in families raises the possibility of shared aetiology. To examine this, we performed cross-trait linkage disequilibrium (LD)-score regression of multiple myeloma (MM) and chronic lymphocytic leukaemia (CLL) genome-wide association study (GWAS) data sets, totalling 11,734 cases and 29,468 controls. A significant genetic correlation between these two B-cell malignancies was shown (Rg = 0.4, P = 0.0046). Furthermore, four of the 45 known CLL risk loci were shown to associate with MM risk and five of the 23 known MM risk loci associate with CLL risk. By integrating eQTL, Hi-C and ChIP-seq data, we show that these pleiotropic risk loci are enriched for B-cell regulatory elements and implicate B-cell developmental genes. These data identify shared biological pathways influencing the development of CLL and, MM and further our understanding of the aetiological basis of these B-cell malignancies.
Collections
Subject
Humans
Multiple Myeloma
Genetic Predisposition to Disease
Case-Control Studies
Organ Specificity
Linkage Disequilibrium
Polymorphism, Single Nucleotide
Alleles
Quantitative Trait Loci
Databases, Genetic
Leukemia, Lymphocytic, Chronic, B-Cell
Genome-Wide Association Study
Genetic Association Studies
Genetic Linkage
Research team
Cancer Genomics
Myeloma Group
Language
eng
Date accepted
2018-11-19
License start date
2018-12-21
Citation
Blood cancer journal, 2018, 9 (1), pp. 1 - ?
Publisher
NATURE PUBLISHING GROUP
Except where otherwise noted, this item's license is described
as
https://creativecommons.org/licenses/by/4.0
Related items
Showing items related by title, author, creator and subject.
-
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism.
Li, N; Johnson, DC; Weinhold, N; Kimber, S; Dobbins, SE; et al. (CELL PRESS, 2017-09-12)Multiple myeloma (MM) is a malignancy of plasma cells. Genome-wide association studies have shown that variation at 5q15 influences MM risk. Here, we have sought to decipher the causal variant at 5q15 and the mechanism by ... -
Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2.
Studd, JB; Vijayakrishnan, J; Yang, M; Migliorini, G; Paulsson, K; et al. (NATURE PORTFOLIO, 2017-03-03)Despite high-hyperdiploid acute lymphoblastic leukaemia (HD-ALL) being the most common subgroup of paediatric ALL, its aetiology remains unknown. Genome-wide association studies have demonstrated association at 10q21.2. ... -
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.
Zeng, C; Guo, X; Long, J; Kuchenbaecker, KB; Droit, A; et al. (BMC, 2016-06-21)BACKGROUND: Multiple recent genome-wide association studies (GWAS) have identified a single nucleotide polymorphism (SNP), rs10771399, at 12p11 that is associated with breast cancer risk. METHOD: We performed a fine-scale ...